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Background: Retention is considered the second highest trial 
methods priority in the UK after recruitment. 
 Methods: This Study Within A Trial (SWAT) evaluated whether 
sending a pre-notification card around one month before a face-to-
face primary outcome measurement visit compared to not sending 
the card increased trial retention. The SWAT was a two-arm, parallel 
randomised (1:1 allocation ratio), stratified by centre, study. It was 
embedded within the ActWELL host trial, which evaluated whether 
women receiving lifestyle change counselling from volunteer coaches 
improved outcomes including weight and physical activity. The text on 
the card was not developed using formal behavioural change theory 
but did target factors thought to influence attendance. 
The SWAT primary outcome was the difference in the proportion of 
participants attending the host trial primary outcome measurement 
visit. The secondary outcome was the direct cost of sending cards. 
Host trial participants and research staff at the primary outcome visit 
were blind to the SWAT. Analysis was intention-to-treat. GRADE was 
used the assess the certainty of evidence. 
Results: 558 host trial participants took part in the SWAT and were 
included in the analysis. Sending a pre-notification card may result in 
a slight increase in attendance at a face-to-face primary outcome 
measurement visit: risk difference = 3.3% (95% confidence interval = -
3.0% to 9.6%). This is GRADE low certainty evidence. A recording error 
meant it was unclear whether 17 participants allocated to the card 
were actually sent one but a sensitivity analysis did not change the 
overall result or conclusion. The direct cost of producing and sending 
the cards was £192 GBP (€213 EUR; $260 USD). 
 Discussion: Trialists could consider using pre-notification as they may 
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gain a slight increase in retention to face-to-face trial measurement 
visits but further evaluations are needed.
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Introduction
Retention is considered the second highest trial methods priority in the UK after recruitment1. A recent UK study found
that the median loss-to-follow-up in a sample of 151 trials was 11%2. Reminders are generally an effective way of
increasing response rates to questionnaires and there is evidence that pre-notification (contacting participants to say that
they will soon be sent a questionnaire) is beneficial, although it is not high certainty evidence3.
There is no clear evidence from the Cochrane systematic review of trial retention interventions that pre-notification is
effective for trial retention for face-to-face visits4. However, at the time the review was published, an ongoing Study
Within ATrial (SWAT) in a trial involvingwomen aged between 70 and 84 years at high risk of osteoporotic fractures did
find that sending a newsletter to participants approximately six weeks before a trial questionnaire increased retention by
around 1%5.
SWAT question
Does sending a pre-notification card around one month before a face-to-face primary outcome measurement visit
compared to not sending the card increase trial retention?
Methods
SWAT protocol
This SWAT is registered on the SWAT repository as SWAT 76. See: http://www.qub.ac.uk/sites/TheNorthernIreland-
NetworkforTrialsMethodologyResearch/FileStore/Filetoupload,864300,en.pdf
Host trial
This SWAT evaluationwas embedded in theActWELL trial (ISRCTN11057518)6. ActWELL evaluates whether women
who receive two, face-to-face lifestyle change sessions from volunteer coaches followed by up to nine telephone calls
over a year, compared to no counselling, improves a range of lifestyle outcomes. The two primary outcomes were weight
change and change in physical activity at 12-months. Women were invited to take part in ActWELL when they attended
their routine mammography appointment (all women aged 50 - 70 in Scotland receive an offer of mammography every
three years) at one of four Scottish National Health Service Breast Screening centres. A total of 560 women were
randomised into the ActWELL trial.
Participants
All host trial participants were eligible.
Intervention
The intervention is a pre-notification card sent around one month before the face-to-face primary outcome measurement
visit. The text on the card was not developed using formal behavioural change theory but did target factors thought to
influence attendance. Women were thanked to make them feel valued, were told their data were valuable regardless of
how things had gone in the trial and the number of other women in the trial was highlighted. The card was signed by the
Chief Investigator of the host trial and the Chief Executive of Breast Cancer Now, the charity involved in delivering the




Primary outcome: the difference in the proportion of participants attending the host trial primary outcome measurement
visit (i.e., retention).
Secondary outcome: the direct cost of sending pre-notification cards.
Sample size
The sample size was determined by the host trial so no sample size calculation was done. See Trial Forge Guidance 1 for
more information about SWAT sample size calculation7.
Randomisation
Two-arm, parallel randomised with a 1:1 allocation ratio, stratified by centre. One of the authors (ST) prepared a central
randomisation list for each centre for up to 150 participants using https://www.random.org/sequences/. This was then
passed to the trial manager and trial administrator who sent out the pre-notification cards.
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Blinding
Women in the host trial had no knowledge of the SWAT. Host trial primary outcome visits were organised and done by
research nurses, who had no knowledge of the SWATor host trial allocation. The SWATprimary outcome, retention, was
objective.
Approvals
The study was approved by East of Scotland Research Ethics Service REC 1 as part of the host ActWELL trial
(17/ES/0073). The low risk nature of the SWAT evaluation meant that individual informed consent from host trial
participants to be involved was not required by the ethics committee, in line with most SWATs in the UK.
Statistical analysis
The difference in the proportion of attended visits between groups was calculated using Comprehensive Meta-Analysis
Version 3 (https://www.meta-analysis.com/).
GRADE was used to assess the certainty of the evidence8. In addition to the numerical result, the result is summarised as
an informative statement as per GRADE Guidelines 269.
Results
Two host trial participants withdrew before the 12-month host trial primary outcome measurement meaning 558 were
included in the SWAT, which ran between March 2018 and July 2019 (Figure 2; Table 1). One host trial centre recruited
151 participants, which was beyond its recruitment target and one participant beyond the randomisation list for that
centre. The extra participant wasmanually allocated to the comparator arm.A discrepancy between the randomisation log
(which indicated who should get a card) and the host trial's tracker system (which confirmed that a card had been sent to a
participant) meant that we could not confirm whether 17 participants who should have been sent the pre-notification card
were actually sent one. Three further participants who should have received a card are known to have not been sent a card
because the participant was called in for a host trial measurement visit before the card could be sent.
The summary statement below and the primary analysis in Table 1 are intention-to-treat as per the randomisation
schedule. A sensitivity analysis done using the tracker data is also shown.
Figure 2. Flow diagram summarising the flow of participants through the SWAT evaluation.
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Summary statement of result: Sending a pre-notification card may result in a slight increase in attendance at a
face-to-face primary outcome measurement visit. Risk difference = 3.3% (95% confidence interval = -3.0% to 9.6%).
GRADE = low certainty evidence.
Direct costs
The direct costs of printing the cards was £72 GBP. Design work was extremely modest, bundled with other host trial
design work and not charged separately. Second class (i.e., delivery within two days) postage costs were run through
the University of Dundee mailroom at an estimated cost of £120 GBP. The total direct cost was therefore £192 GBP
(€212 EUR; $259 USD).
Discussion
Sending a simple card about one month prior to a face-to-face primary outcome measurement visit may result in a slight
improvement in attendance. This is GRADE low certainty evidence because there is just this single evaluation and it is
imprecise.
We are not aware of other pre-notification interventions that target face-to-face trial visits. An upcoming 2021 update of
the Cochrane retention review4 found no additional pre-notification studies (ST is a co-author of this update). Mitchell
and colleagues5 added their evaluation to a meta-analysis of pre-notification evidence done outside trials and healthcare.
As might be expected, there was substantial heterogeneity but the overall direction of effect was also in favour of pre-
notification.
Table 1. Attendance at the 12-month primary outcome measurement visit for those sent a pre-notification
card and those not sent a card. A sensitivity analysis was done to explore the impact of a record-keeping error (see
main text).
Attendance at 12-months- Intention-to-treat analysis (SWAT primary analysis)
Allocated to be sent a pre-notification
card (n=274)*
Allocated to not be sent a
notification card (n=284)






Risk difference (95% confidence
interval)
231 (84%) 43 (16%) 230 (81%) 54 (19%) 3.3%
(-3.0% to 9.6%)
*This includes three participants who were allocated to receive a card but who are known not to have been sent
one.
Attendance at 12-months- As per tracker system (sensitivity analysis)
Tracker registers participant was sent
a pre-notification card (n=254)
Tracker registers participant
was not sent a notification
card (n=304)






Risk difference (95% confidence
interval)
213 (84%) 41 (16%) 248 (82%) 56 (18%) 2.3%
(-4.0% to 8.6%)
GRADE assessment
Study limitations No serious issues.
Inconsistency of
results




Imprecision Downgrade 1 level because confidence interval is wide and crosses risk difference of 0.
Reporting bias No serious issues.
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Strengths and limitations
We had a record-keeping error, which means we cannot say with confidence that all participants who should have been
sent a pre-notification card were sent one. However, the number of participants affected was relatively small and our
overall results and conclusion remain the same regardless of whether we analyse according to the randomisation schedule
or the tracker system. There are currently only two evaluations of pre-notification in trials, our own of cards aimed at
face-to-face visits and that of Mitchell and colleagues of a newsletter to increase questionnaire response5. This does not
provide a broad range of contexts for this evidence base. Both evaluations were done in the UK and in women only.
Implications for trial practice
Trialists could consider using pre-notification as they may gain a slight increase in retention to face-to-face trial
measurement visits.
Implications for SWAT research
Looking at the existing evidence and referring to Trial Forge Guidance 2 as to whether further SWATs evaluating this
intervention are required10, we conclude that more evaluations are needed because the GRADE certainty in the evidence
is not high, there is only a single evaluation meaning cumulative meta-analysis cannot converge and few host trial
contexts are included.
Further evaluations of pre-notification in trials could target either face-to-face or questionnaires but should aim to add




Open Science Framework: SWAT 76 data for host trial ActWELL, https://doi.org/10.17605/OSF.IO/N64HU11
This project contains the following underlying data:
Primary analysis 8-1-2021 (public).csv
Sensitivity analysis 8-1-2021 (public).csv
Reporting guidelines
Open Science Framework: CONSORT checklist for ‘SWAT 76 evaluation: randomised evaluation of sending pre-
notification cards to trial participants before a face-to-face primary outcomemeasurement to increase attendance’, https://
doi.org/10.17605/OSF.IO/B78JT12
Data are available under the terms of the Creative Commons Attribution 4.0 International license (CC-BY 4.0).
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Michelle E. Kho   
School of Rehabilitation Science, McMaster University, Hamilton, ON, Canada 
Treweek et al. conducted a study within a trial to evaluate whether a post card sent 1 month prior 
to an in-person primary outcome research visit improved retention within the multicentre 
ActWELL randomized trial of lifestyle coaching. 558 participants from the host trial were sent a 
pre-notification card. Of this cohort, 84% who were allocated a pre-notification card attended the 
primary outcome visit, compared to 81% who were not allocated a pre-notification card. This is a 
well-written, well-designed, and well-reported study. It will make important contributions to 




Results – To help the reader understand the impact on the trial, I recommend the authors 
first report the total number of women who attended their primary outcome follow-up visit, 
then report the proportion by group. 
 
1. 
Results – I initially found Table 1 confusing. Since those who did not attend the visit is the 
complement of those who did attend a visit, I suggest reporting only those who attended 
the visit. The risk difference represents the difference between those who attended the 
visit. I also suggest adding the 95% CI around the estimates, and report 1 decimal point for 
consistency with the risk difference. 
 
2. 
Can the authors report whether patients recalled receiving the pre-notification card before 
their outcomes visit? 
 
3. 
Implications for trial practice – I suggest adding text to further contextualize the 
implications of the relative cost of this intervention, the overall investment costs in the 
enrolled patients to-date, and the importance of ascertaining the primary outcome. Even a 
3% improvement in primary outcome ascertainment could affect trial results.
4. 
Minor issues:
Abstract – I suggest reporting absolute values in the intervention and control groups, then 1. 
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the risk difference. 
 
Introduction – I suggest adding a statement regarding the importance of the primary 
outcome in a trial and the need for interventions to optimize ascertainment. 
 
2. 
Intervention – I suggest moving the text regarding behavioural change theory in the 




Results – Data error for 17 participants (3%) – suggest also reporting % of total group to 
help the reader easily evaluate the small number. Interestingly, the risk difference was also 
3%. The authors conducted a sensitivity analysis, and the results were similar. I suggest this 
is also a strength of the study. 
 
4. 




Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
Competing Interests: No competing interests were disclosed.
Reviewer Expertise: Critical care clinical trials; health research methodology; rehabilitation; 
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© 2021 Sutton C. This is an open access peer review report distributed under the terms of the Creative Commons 
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited.
Christopher Sutton   
Centre for Biostatistics, University of Manchester, Manchester, UK 
Overall, this is an excellent manuscript and an extremely welcome and useful addition to the 
literature on trial retention.  The work provides a clear citation of the relevant literature. 
 
The methodology is sound and the trial performed well; it has significant academic merit. There 
are, however, aspects of the methods and analysis which are a little under-specified and unclear, 
and suggestions for clarification are detailed below.  Likewise, the statistical and economic 
analysis is appropriate, although I do suggest additional analyses and results be presented to 
enhance interpretation and generalisability.  
 
The source data underlying the results are available.  The conclusions are drawn adequately and 
supported by the results, with an appropriate sensitivity analysis performed to investigate the 
potential impact of some degree of failure to definitively send the pre-notification card to 20 
participants allocated to receive the card. 
 
Specific comments:
Introduction:  clearly state that the previous SWAT of the impact of a newsletter on 
retention was statistically significant (p<0.05 … just!). 
 
1. 
I would query the statement that “All trial participants were eligible.”  From my perspective, 
the eligibility criteria were (a) Trial participant of the ActWELL trial (b) remaining in ActWELL 
at 1 month prior to the 12-month final follow-up. 
 
2. 
The primary outcome would be better specified as a binary outcome measure (i.e. at the 
participant level e.g. “attendance at the host trial primary outcome measurement visit”). 
 
3. 




In line with CONSORT 2010, for binary outcome measures both absolute and relative 
measures of effect are recommended.  Across different trial populations, interventions, 
duration of follow-up etc., it is likely that there are different ‘control’ rates of retention and 
the impact of any intervention is probably more likely to be on a relative rather than an 
absolute scale.  For example, the newsletter trial referenced in the Introduction (Mitchell et 
al., (2012)) had a control group retention rate of 94.6% (and an absolute increase of 1.6% in 
the intervention group), compared with this trial which had a control group retention rate of 
81.0% (and an absolute increase of 3.3%).  It is therefore recommended that the results are 
also presented as a Risk Ratio (Relative Risk) or Odds Ratio. 
 
5. 
I would like to see more information on the economic analysis.  For example, how much did 
the intervention cost per participant retained? 
6. 
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In the Discussion and Strengths and Limitations, the authors state that there are no 
additional pre-notification studies; it would be better to stated that there are no additional 
completed pre-notification studies (there are at least two other pre-notification trials 
registered on the SWAT Repository Store (SWAT77 and SWAT86). 
 
7. 
Reference list: references 11 and 12 re identical (Reference 12 should refer to the CONSORT 
checklist for this SWAT).
8. 
 
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Yes
If applicable, is the statistical analysis and its interpretation appropriate?
Partly
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Yes
Competing Interests: I am a Co-Investigator on the MRC-funded "Routinely embedding 
recruitment and retention interventions within randomised controlled trials" [PROMETHEUS] 
project with the lead author, Shaun Treweek.
Reviewer Expertise: Clinical trial methodology, particularly around trial conduct and retention 
methods.
I confirm that I have read this submission and believe that I have an appropriate level of 
expertise to confirm that it is of an acceptable scientific standard.
 
Page 13 of 14
F1000Research 2021, 10:84 Last updated: 27 APR 2021
The benefits of publishing with F1000Research:
Your article is published within days, with no editorial bias•
You can publish traditional articles, null/negative results, case reports, data notes and more•
The peer review process is transparent and collaborative•
Your article is indexed in PubMed after passing peer review•
Dedicated customer support at every stage•
For pre-submission enquiries, contact research@f1000.com
 
Page 14 of 14
F1000Research 2021, 10:84 Last updated: 27 APR 2021
